COVID-19 and the Developement of Phobic Fears of Disease

COVID19 Clinical Trial

Official title:

COVID-19 and the Developement of Phobic Fears of Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04359121
• Other study ID #: 32-354 ex 19/20
• Status: Recruiting
• Start date: December 15, 2020
• Est. completion date: November 15, 2023

Study information

• Verified date: January 2023
• Source: Medical University of Graz
• Contact: Andreas Baranyi, Prof.
• Phone: 0043-316-385-86241
• Email: an.baranyi[@]medunigraz.at
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - physicians, medical staff, general public (not medically affiliated) and patients with psychiatric disorders.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: November 15, 2023
• Est. primary completion date: November 15, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Person gives written consent

• Persons between 18-90 years of age (men and women)

• No positive COVID infection known at time of first examination

Exclusion Criteria:

• Dementia, Delirium (not able to give consent)

• Not fulfilling the inclusion criteria

• COVID infection known at first examination point

Related Conditions & MeSH terms

• COVID-19
• COVID19

Intervention

Other:
• Questionnaires for specific phobia
Questionnaires will be used.

Locations

Country	Name	City	State
Austria	Medical University of Graz	Graz	Styria

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Development of phobias	Specific Phobia Questionnaire (SPQ): The SPQ consists of 43 items, each rated using a 5-point Likert scale on two dimensions: (1) level of fear, with scores ranging from 0 (no fear) to 4 (extreme fear) and (2) extent to which the fear interferes with one's daily life, with scores ranging from 0 (no interference) to 4 (extreme interference). The SPQ is scored by combining fear ratings of each Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) specific phobia type.; Severity Measure for Specific Phobia-Adult: The total score can range from 0 to 40 with higher scores indicating greater severity of specific phobia.	2 years